A Targeted Biotech ETF Is Brushing Off the Selling

Among the ares of the market that escaped the ongoing bloodshed on Wednesday, a biotechnology sector-related exchange traded fund stood out on better-than-expected quarterly earnings results and developing vaccines to combat the spreading coronavirus. The ARK Genomic Revolution Multi-Sector Fund...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.